We were somewhat surprised and quite dismayed to read the publication 'The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation' by Soundararajan et al. published in this issue of Innate Immunity. 1 This article, as well as another by the same group published earlier this year in PLOS One, 2 describes the group's development of computational algorithms for determining the network of intramolecular interactions between residues in the YopM protein, as well as those between the YopM protein and other interaction partners. In both articles, the authors describe a protein that they identify as YopM (NCBI ID ZP_02316950.1). The main problem with this analysis is that the protein they model is not, in fact, YopM. The YopM protein of Yersinia is encoded on the virulence plasmid (pCD1 in Y. pestis, pYV in Y. enterocolitica and Y. pseudotuberculosis). Although there is some sequence heterogeneity in the YopM protein, 3 the main feature of the protein is that it consists of 13-21 leucine rich repeats and does not encode a C-terminal novel E3 ubiquitin ligase (NEL) domain or any other putative catalytic domain. 4 The original articles describing the E3 ubiquitin ligase domain, [5] [6] [7] demonstrate that they are important for usurping elements of the host immune response. The first report of this activity showed that in Saccharomyces cerevisiae, the IpaH9.8 protein can bind to and ubiquitinate the Ste7 protein in the yeast pheromone signaling pathway, thereby blocking the pathway. 5 The SlrP protein of Salmonella enterica is able to interact with both thioredoxin and ERdj3 protein of the host. [8] [9] In mammalian cells, the IpaH9.8 protein of Shigella binds to and inactivates the NF-kB signaling protein, NEMO, via the action of the NEL domain. 10 As described by the authors, an emerging paradigm suggests that this family of molecules utilizes the N-terminal LRR domain to impart substrate specificity on the E3 ubiquitin ligase domain of the NEL domain. In fact, crystallographic data suggests that the leucine-rich repeats (LRR) domain maintains the NEL domain in an inactive conformation until the LRR domain binds to a specific substrate and liberates the enzyme active site from allosteric inhibition. 7 It is true that the genus Yersinia contains a number of proteins with homology to the LRR family of effectors, some of which also possess NEL domains as described. 6, 11 Depending upon the species examined, each particular strain of Yersinia may contain up to five chromosomally-encoded LRR proteins and, of these, at least two also possess the E3 ubiquitin ligase domain. For example, in the well-characterized Y. pestis KIM strain, there are five LRR proteins (y1460-NP_668780; y1471 -NP_668791; y3397-NP_670696; y3399-NP_670698; y3400-NP_670699) and they are all distinct from the YopM protein (NP_857756). One of these proteins (y3397-NP_668791) appears to be identical to the accession number identified by the authors of these articles as YopM. To date, there has been no systematic study of these proteins that we are aware of and, while it is tempting to speculate on the potential function of this class of proteins, it is important to do so within the confines of what has been experimentally demonstrated.
To this end, the conclusions of both of these articles must be taken with a large grain of salt given that the analysis is based upon a false assumption: that the protein described is the same YopM protein that has been widely studied and reported on in the literature. There are also a number of other smaller errors in the article: the authors speculate that the protein they are describing may interact with TLR4 owing to their calculations and that this interaction may contribute to the poor endotoxicity associated with Y. pestis infection. 12 While it has been shown that Yop translocation can result in reduced MAP kinase activity through the activity of YopJ, [13] [14] the reduced endotoxicity associated with 37 C-grown Yersinia can be recapitulated with purified LPS alone. 15 The authors also state, and include in their model, that YopM interacts with IL-15-such an interaction has never been demonstrated, although it is true that work from Dr Straley's group has suggested that IL-15 mRNA is regulated in a YopM-dependent manner. 16 The authors also state that the interaction between the C-terminus of the YopM protein and RSK1 is caused by the loss of this NEL domain-a statement that is simply not supported by the literature. 17, 18 While we admire the effort to apply advanced mathematical-modeling algorithms to the topic of host-pathogen interactions, and we agree with the authors that there are likely major advances that can be made to that end, this article simply confuses and obfuscates the scientific literature on the study of the YopM protein and this letter is an attempt to right that wrong.
Sincerely, Dr Joseph B McPhee and Dr James B Bliska
Response by V Soundararajan et al.
Email: rams@mit.edu
McPhee and Bliska have commented on the nomenclature of the Yersinia pestis protein that was modeled and analyzed in our original study (NCBI Reference Sequence ZP_02316950.1 with GenPept resource page: www.ncbi.nlm.nih.gov/protein/167425197). 1 As is evident, GenPept has defined this protein as 'Outer Membrane Protein YopM [Yersinia pestis biovar Mediaevalis str. K1973002]' and noted this as a Type III secretion system leucine rich repeat protein [pfam12468] from the gene YopM, with locus tag of YpK1973002_0516 and coded by the complement Letter NZ_AAYT01000005.1:66961..68841 ( Figure  1 ). Residues 9..60 towards the N-terminal end of this protein have further been noted by NCBI as part of the Type III secretion system leucine rich repeat protein; pfam12468. Our study was the first to identify, model and analyze the structure-function relationship of a novel E3 ligase (NEL) domain towards the C-terminal segment of this protein beyond its N-terminal LRR domain. 1 Our study's reviewers found this to be a salient contribution to the emerging understanding that NEL domains can be critical components of bacterial effectors and virulence factors. [2] [3] [4] [5] The protein indicated by McPhee and Bliska (NCBI Reference Sequence NP_857756 with GenPept resource page: http://www.ncbi.nlm.nih.gov/protein/ 31795297) has been described as 'Similar to outer membrane protein YopM' by NCBI and extensively investigated by prior experimental studies. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] This Y. pestis protein (NP_857756) is 409 amino acids in length and primarily consists of the LRR domain 
Antigenic leucine-rich repeat protein
Putative antigenic leucine-rich repeat protein without a C-terminal domain, such as the one identified by us as the NEL domain in the Y. pestis protein ZP_02316950.1. In this regard, it is worth noting that, following publication of our Innate Immunity article, Stuart W. Hicks and Jorge E. Gala´n provided the NEL-containing YopM-like LRR proteins YPA_3361 and YPA_3364 as examples of bacterial effectors that are E3 ligase mimics in a review article. 19 Hicks and Galan note in Table 1 of this review that 'These are representative open reading frames from Yersinia pestis Angola that are found in most Yersinia pestis and Yersinia pseudotuberculosis strains'. 19 It is seen that the protein encoded by YPA_3361 (YP_653268.1) has the same amino acid sequence as (100% identical to) the protein analyzed by our study (ZP_02316950.1) and that these are highly homologous to the protein encoded by YPA_3364 (YP_653271.1) ( Figure 2 ). This observation further motivates experimental exploration of the NEL-containing Y. pestis proteins that were identified, modeled and analyzed by our original study. 1 Our identification of NEL-containing LRR proteins in Y. pestis (such as ZP_02316950.1) with homology to NEL-absent LRR proteins (such as NP_857756) (Figure 3 ), prompted analysis of the spectrum of their possible host-impinging functions-as pointed out in our original study. The need for experimental investigation of each hypothesized function was clearly emphasized by the '?' (question mark) symbol in all our figures. 1 The identification and structural characterization of NEL-containing LRR proteins (such as ZP_02316950.1) in different Y. pestis strains (Table 1) by our study add to the wealth of knowledge on the host-impinging functions of NEL-absent proteins in different Y. pestis strains [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and underline the need for thorough experimental investigation of both NELcontaining and NEL-absent YopM-like proteins encoded by different Y. pestis strains by future studies. The fact that NEL-absent YopM-like LRR proteins from Y. pestis do not explain many of the known virulence-determining properties of Y. pestis effectors, as is readily acknowledged in the literature, highlights the importance of such study.
The letter suggests that our papers describe the 'development of computational algorithms for determining the network of intramolecular interactions between residues in the YopM protein as well as those between the YopM protein and other interaction partners'. As mentioned in our Materials and methods section, 1, 20 inter-residue contacts were computed purely to estimate the structural folds of the domains from sequence, whereas a combination of structural superposition and interface analysis tools were used to estimate potential interaction partners. Intramolecular interactions between residues in the YopM protein were not used for any computations 'on the YopM protein and other interaction partners' as stated in their letter. The statement that 'the genus Yersinia contains a number of proteins with homology to the LRR family of effectors, some of which also possess NEL domains as described'. 6, 11 is not supported by the cited references 6 and 11. These papers have noted the homology of LRR domain-containing effectors from Shigella to the LRR domain from Y. pestis YopM, 14, 15 but have not investigated NEL-containing YopM-like proteins from Y. pestis.
The data available from NCBI regarding NEL-containing LRR proteins encoded by the genomes of different Y. pestis strains sequenced to date, indicates that there are instances of Y. pestis strains that are not seen to have any E3 ubiquitin ligase domains ( Table 2 ). The strains Y. pestis Angola, Y. pestis biovar Antiqua str. UG05-0454 and Y. pestis str. Pestoides F offer some examples that do not appear to encode any tangible NEL-containing YopM-like proteins based on the data available from NCBI. Furthermore, there are over 16 strains of Y. pestis for which data from sequencing projects are yet to be deposited. Finally, as clearly demonstrated by the results presented in our studies 1, 20 , our fold/ functional similarity identification methodology goes beyond traditional sequence-based or structure-based homology identification algorithms and is vastly effective, irrespective of the degree of evolutionary tinkering. This factor was critical to enabling our high throughput identification of NEL-containing YopM-like proteins from different bacteria. The fact that the minimum number of NEL-containing (E3 ubiquitin ligase domain) proteins in each Yersinia strain may not be two, highlights why interresidue contact networks analysis methodologies from our group and others are emerging as novel tools for mapping hitherto unknown evolutionary, functional and structural relationships between proteins. In their aggregate, these factors suggest that a careful analytical and experimental investigation of the presence or absence of NEL domains in YopM-like proteins encoded by different Y. pestis strains building on methodologies demonstrated to be effective in a diverse set of systems are required from future studies. Our vision is that such efforts would serve to decode the many faces of YopM-like proteins encoded by Gammaproteobacteria of the Yersinia genus.
